<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liegeois MA</submitter><funding>National Science Foundation Graduate Research Fellowship Program</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NIAID</funding><funding>NIH HHS</funding><funding>Cystic Fibrosis Trust</funding><funding>NIH National Heart Lung and Blood Institute</funding><pagination>e181024</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11383604</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(15)</volume><pubmed_abstract>Mucus plugs occlude airways to obstruct airflow in asthma. Studies in patients and in mouse models show that mucus plugs occur in the context of type 2 inflammation, and studies in human airway epithelial cells (HAECs) show that IL-13-activated cells generate pathologic mucus independently of immune cells. To determine how HAECs autonomously generate pathologic mucus, we used a magnetic microwire rheometer to characterize the viscoelastic properties of mucus secreted under varying conditions. We found that normal HAEC mucus exhibited viscoelastic liquid behavior and that mucus secreted by IL-13-activated HAECs exhibited solid-like behavior caused by mucin cross-linking. In addition, IL-13-activated HAECs shows increased peroxidase activity in apical secretions, and an overlaid thiolated po</pubmed_abstract><journal>JCI insight</journal><pubmed_title>Peroxidase-mediated mucin cross-linking drives pathologic mucus gel formation in IL-13-stimulated airway epithelial cells.</pubmed_title><pmcid>PMC11383604</pmcid><funding_grant_id>NA</funding_grant_id><funding_grant_id>U19 AI077439</funding_grant_id><funding_grant_id>P01 HL107202</funding_grant_id><funding_grant_id>R01 HL080414</funding_grant_id><funding_grant_id>HL080414,HL107202</funding_grant_id><funding_grant_id>S10 OD028611</funding_grant_id><funding_grant_id>R01 HL164787</funding_grant_id><funding_grant_id>AI077439</funding_grant_id><pubmed_authors>Moore WC</pubmed_authors><pubmed_authors>Wenzel SE</pubmed_authors><pubmed_authors>Braunreuther M</pubmed_authors><pubmed_authors>Castro M</pubmed_authors><pubmed_authors>Woodruff PG</pubmed_authors><pubmed_authors>Fuller GG</pubmed_authors><pubmed_authors>Fahy JV</pubmed_authors><pubmed_authors>Charbit AR</pubmed_authors><pubmed_authors>Levy BD</pubmed_authors><pubmed_authors>Raymond WW</pubmed_authors><pubmed_authors>Jarjour NN</pubmed_authors><pubmed_authors>Tang M</pubmed_authors><pubmed_authors>Israel E</pubmed_authors><pubmed_authors>Erzurum SC</pubmed_authors><pubmed_authors>Liegeois MA</pubmed_authors><pubmed_authors>Christenson SA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Peroxidase-mediated mucin cross-linking drives pathologic mucus gel formation in IL-13-stimulated airway epithelial cells.</name><description>Mucus plugs occlude airways to obstruct airflow in asthma. Studies in patients and in mouse models show that mucus plugs occur in the context of type 2 inflammation, and studies in human airway epithelial cells (HAECs) show that IL-13-activated cells generate pathologic mucus independently of immune cells. To determine how HAECs autonomously generate pathologic mucus, we used a magnetic microwire rheometer to characterize the viscoelastic properties of mucus secreted under varying conditions. We found that normal HAEC mucus exhibited viscoelastic liquid behavior and that mucus secreted by IL-13-activated HAECs exhibited solid-like behavior caused by mucin cross-linking. In addition, IL-13-activated HAECs shows increased peroxidase activity in apical secretions, and an overlaid thiolated po</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jun</publication><modification>2026-05-02T12:45:08.133Z</modification><creation>2025-04-04T00:29:54.178Z</creation></dates><accession>S-EPMC11383604</accession><cross_references><pubmed>38889046</pubmed><doi>10.1172/jci.insight.181024</doi></cross_references></HashMap>